EVERSIDE CAPITAL PARTNERS
EVERSIDE CAPITAL PARTNERS is a Seed, Series C+, buyout, debt and secondary fund in the US investing in Healthcare, business-services and niche-manufacturing.
- Stages
- Seed, Series C+, buyout, debt, secondary
- Sectors
- Healthcare, business-services, niche-manufacturing
- Invests in
- US-wide
- Round role
- Leads and follows
- Actively investing
- Yes
- Founded
- 2016
- Assets under management
- $3.1B
- Website
- everside.com
Check size not disclosed
Thesis
Everside Capital Partners, founded in 2016 and based in New York City, is an investment firm focused on the U.S. lower middle market. They provide flexible capital solutions via direct lending, debt, and structured equity, and also invest in lower middle market debt and equity funds, particularly SBICs. Everside operates through three verticals: Primaries (fund commitments, seed capital), Secondaries (liquidity solutions), and Directs (tailored debt and equity investments). They act as both lead and follow investors, utilizing debt and structured equity instruments. As of December 31, 2024, their regulatory AUM was approximately $1.92 billion, with $1.82 billion managed discretely. Other reports indicate AUM around $1.9 billion as of March 2025 and $3.1 billion across funds. One fund, Everside Capital Partners IV, is a $600 million direct lending fund. The firm is an SEC-registered investment advisor, an SBIC license holder, and a Certified B Corporation.
Common questions
Does EVERSIDE CAPITAL PARTNERS invest at the Seed stage?
Yes. EVERSIDE CAPITAL PARTNERS lists Seed, Series C+, buyout, debt and secondary among the stages it invests in.
Where does EVERSIDE CAPITAL PARTNERS invest?
EVERSIDE CAPITAL PARTNERS invests in the US.